Study Population
AML . | No. . | ALL . | No. . | NHL . | No. . |
---|---|---|---|---|---|
M0 | 1 | pre-B ALL | 9 | B-cell chronic lymphocytic leukemia | 2 |
M1 | 3 | B ALL | 3 | Small lymphocytic lymphoma | 2 |
M2 | 5 | T ALL | 4 | Immunocytoma | 1 |
M3 | 8 | Plasmacytoma | 1 | ||
M4 | 7 | Follicle center lymphoma | 7 | ||
M5 | 4 | Mantle cell lymphoma | 3 | ||
Hybrid | 1 | Diffuse large B-cell lymphoma | 5 | ||
Total | 29 | total | 16 | total | 21 |
AML . | No. . | ALL . | No. . | NHL . | No. . |
---|---|---|---|---|---|
M0 | 1 | pre-B ALL | 9 | B-cell chronic lymphocytic leukemia | 2 |
M1 | 3 | B ALL | 3 | Small lymphocytic lymphoma | 2 |
M2 | 5 | T ALL | 4 | Immunocytoma | 1 |
M3 | 8 | Plasmacytoma | 1 | ||
M4 | 7 | Follicle center lymphoma | 7 | ||
M5 | 4 | Mantle cell lymphoma | 3 | ||
Hybrid | 1 | Diffuse large B-cell lymphoma | 5 | ||
Total | 29 | total | 16 | total | 21 |
The AMLs were classified morphologically according to the French-American-British classification,19 and NHLs were classified according to the REAL classification.20 ALLs were classified according to their immunophenotype as reported.21